Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose esketamine combined with propofol for pediatric painless gastroenteroscopy
ChiCTR2200060345Phase 4Recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine (2 arms), sponsored by Beijing Children's Hospital. Primary endpoint: Intraoperative propofol dose. Started May 2022; status: recruiting.
02
Drugs
esketamine
Beyond the preview
Go deeper on ChiCTR2200060345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060345.